Three in four eating disorder patients are not referred for specialist care, UK study suggests body weight may be a factor. Find out more in @lancetprimarycare.bsky.social: spkl.io/633267zsbC
The Lancet
@thelancet.com
Welcome to The Lancet, one of the world’s leading medical journals, published weekly since 1823. 🌐 thelancet.com
📢Register now for our free #Webinar "Transforming the Landscape of #GynaecologicalCancer: Advances in Prevention, Precision Surgery, and Innovative Systemic Therapies" on Sept 3: irc.ad/the-lancet-g... Read the linked Series here: thelancet.com/series-do/gy... @chrustrasbourg.bsky.social
Triple-negative breast cancer is the most aggressive form of the disease, & it often spreads to the brain. Treatment options remain limited. A Review in @thelancetoncol.bsky.social draws together the latest evidence to provide a roadmap for unmet clinical needs. Find out more: tinyurl.com/3s3nez22
Novel strategies to overcome the blood–brain barrier in triple-negative breast cancer brain metastases
Triple-negative breast cancer—the most aggressive breast cancer subtype—has a high propensity for brain metastases, with limited treatments and poor prognosis. The blood–brain barrier, long viewed as ...
tinyurl.com
From recent medical breakthroughs to science policy & social commentary: in @thelancet.com Voice Podcast, researchers, policymakers & practitioners unravel stories of groundbreaking health & clinical research, exploring the implications for the health of everyone spkl.io/6332071qTw
Multimedia | Podcasts | The Lancet Voice
If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password
spkl.io
In today’s issue of @thelancet.com I reflect on the importance of context in #inequalities #research, where nuanced understanding demands more than just a sound bite 💬 or stock photograph 📸 which potentially stigmatises those from disadvantaged communities www.thelancet.com/journals/lan...
Once rapidly fatal diseases without approved therapeutic options, systemic amyloidoses are now highly treatable. A new Review summarises treatment advancements and future directions in systemic light chain and transthyretin amyloidosis: spkl.io/633277KhbB
🆕 #Japan healthcare system is widely cited for #UniversalHealthCoverage and longevity. With #aging & higher care #cost, the system now confronts pressures. A new review proposes a #Vision2040 framework to provide a roadmap for #policy reform aligned with societal value. 🔗 tinyurl.com/mr25xjuy
Japan's health system toward 2040: structural challenges and a renewed social contract
Japan's universal health coverage system has supported healthy longevity, but now confronts institutional stagnation: widely recognised structural pressures persist without reform of its core architec...
thelancet.com
The optimal duration of dual antithrombotic therapy after percutaneous coronary intervention (PCI) in patients with atrial fibrillation remains uncertain. A recent study compared the efficacy and safety of 1-month versus 12-month dual antithrombotic therapy: spkl.io/633217KhVl
"One of the biggest stories this week wasn't about a drug. It was about something far more familiar..." Lancet authors join our Editors to discuss highlights from #AAIC2026 & what excites them about the future of Alzheimer's Disease & dementia research. 🎧 Listen now: spkl.io/633277K7eS
Professor @arricoomarasamy.bsky.social , has been featured in a @thelancet.com Profile recognising his outstanding women's health research and its impact on maternal health globally. Read the article: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)01190-6/abstract @ox.ac.uk
thelancet.com
Amyloidosis care has changed dramatically in the last decade. New therapies, better diagnosis, and multidisciplinary collaboration have improved outcomes—but access remains unequal. What can other rare diseases learn from this progress? Our Editorial: tinyurl.com/4ab7nhtp
Learning from a decade of progress in amyloidosis
Improving outcomes for people with rare diseases is a major challenge, but it is possible. Amyloidosis is a heterogeneous group of rare disorders in which amyloid (misfolded protein deposits) accumula...
tinyurl.com
In our latest issue, the first major dementia-prevention study in Latin America finds that a structured healthy-lifestyle programme boosts memory and thinking in at-risk older adults. Find out more: spkl.io/633227K7ww #AAIC2026
Psoriasis is a common, chronic skin disease affecting more than 60 million individuals worldwide. In a new Seminar, authors provide an updated survey of current knowledge on psoriasis, its clinical management, and key future challenges: spkl.io/633247Kmmj
New online @thelancet.com: the HOPE-3 trial of deramiocel heart-derived cellular therapy in advanced Duchenne muscular dystrophy www.thelancet.com/journals/lan...
Deramiocel heart-derived cellular therapy in advanced Duchenne muscular dystrophy (HOPE-3): a phase 3, randomised, double-blind, placebo-controlled trial
Deramiocel safely slows disease progression in advanced DMD, preserving skeletal muscle function. Administered quarterly in a simple outpatient regimen, deramiocel is a promising treatment for DMD, ag...
thelancet.com
Bloodstream-delivered cell therapy slows muscle decline in young people with Duchenne muscular dystrophy, phase 3 trial finds. Explore the research 👉 spkl.io/633207KSdn
Mental disorders are leading contributors to disease burden among young people. A new study in @lancetrh-wpac.bsky.social provides current estimates of prevalence, patterns, severity, and profiles of mental disorders among Australians aged 16–24. Find out more: tinyurl.com/2t6849am
Rates and impact of mental disorders among Australian youth: prevalence, severity, and trends from two national psychiatric surveys
Mental disorders among Australian youth have increased markedly since 2007, with greater severity and functional impairment.
tinyurl.com
Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial spkl.io/633257KRAX
More people are ageing with HIV than ever before. A new Commission in The Lancet HIV calls for HIV care that supports healthy ageing through better prevention, person-centred care, & stronger health systems: tinyurl.com/32y4yez7 #IAS2026 #AIDS2026 @iasociety.bsky.social
Blood pressure and cholesterol levels in adults over 40 with obesity increasingly similar to adults with normal BMI, study suggests in The Lancet. Explore the research 👉 spkl.io/633297JLZN
New Review—Inherited retinal degenerations: clinical phenotypes and emerging therapies spkl.io/633297JLRh
Who owns cardiometabolic disease? Many people with interconnected conditions navigate multiple clinics and care plans. Our latest Editorial discusses whether it's time to rethink how cardiometabolic care is organised. Read more: spkl.io/633217JI79
On the cover, a new Comment explores the intersection between climate, war, and the global health-care supply chain. Read this & more: spkl.io/633237JL1x
🔔 Discover The Lancet Surgery & Anaesthesiology, a new journal with a sharp clinical focus, dedicated to advancing science across the full extent of #surgery, #anaesthesiology, and #perioperative specialties, across the age spectrum, and across the globe: spkl.io/633237JQbc
Irritable bowel syndrome (IBS) affects 5–10% of people worldwide. A new Review discusses the current understanding of the pathophysiology of IBS in terms of peripheral, central, and integrated mechanisms. Read in @lancetgastrohep.bsky.social: tinyurl.com/5cankju9
📣 Save the date: 18 September 2026! Join the inaugural Gustave Roussy–Lancet Lecture Series on Cancer Breakthroughs to explore personalised cancer prevention with Prof. Timothy R. Rebbeck. Join in Paris or online at 17:00 CEST. Register: spkl.io/633237yT1P
PMOS linked to four-fold increased risk of heart disease in women, new large US study suggests in @lancetobgyn-wh.bsky.social Read now: tinyurl.com/yvkzhej8
Obesity is increasingly addressed with disease-modifying medications, with benefits that extend across other conditions. A Review in @thelancetendo.bsky.social explores the multisystem benefits of obesity medications beyond weight loss: tinyurl.com/46tsf8rf
Beyond weight loss: multisystem benefits of obesity medications
Obesity is increasingly managed with medications as disease-modifying therapies, reflecting its role as a gateway disease driving metabolic, cardiovascular, reproductive, neuropsychiatric, and mechani...
thelancet.com
1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial spkl.io/633277y0Iv
Currently approved mRNA vaccines are safe and effective at preventing infectious diseases, with promise for future disease prevention and treatment, review confirms. Read more: spkl.io/633207y0ZI
How will AI change the NHS? The NHS is rolling out AI triage tools & ambient scribes across general practice — Niall Boyce & Chloe Wilson discuss in a new episode of #LancetVoice 🎧 Listen now: spkl.io/633277yNQD
How will AI change the NHS? | The Lancet Voice
Can an algorithm decide who sees a doctor first — and what happens when it gets the call wrong? The NHS is rolling out AI triage tools and ambient scribes across general practice, promising to shorten waiting lists and free up clinician time. In this episode of The Lancet Voice, host Niall Boyce and Chloe Wilson, senior editor at The Lancet, cast a questioning eye over the initiative. Chloe raises concerns about AI triage — including the risk of downgrading seemingly innocuous but important symptoms — and questions whether AI in health care is adding efficiency, or simply cutting costs. The hosts also examine ambient scribes in the consulting room, discussing how AI scribes may change clinical practice, or even deskill physicians. The issue isn't whether AI can help the NHS — it's whether we're asking it to do the right things, and if we are implementing it in the right way. Let us know your thoughts in the comments! The Lancet Voice is part of the Lancet Group podcast offering. Editorial team: Niall Boyce, Miriam Sabin, Jessamy Bagenal, Richard Horton, and Gavin Cleaver Podcast editing: Matteo Simonetti Visit http://spkl.io/633247yNQ6 learn more about our multimedia offering. Find the best science for better lives at thelancet.comFollow us today at...http://spkl.io/633257yNQB
spkl.io